Skip to main content

Table 4 Study III echocardiography

From: Systemic and cardiac susceptibility of immune compromised mice to doxorubicin

  

5 weeks

CONTROL

DOXORUBICIN

Parameter

Unit

MEAN

SE

MEAN

SE

LVAW;d

mm

0.90

0.11

0.79

0.06

LVAWS;s

mm

1.18

0.05

1.04

0.07

LVID;d

mm

2.98

0.17

3.50*

0.16

LVID;s

mm

1.69

0.14

2.50*

0.22

LVPW;d

mm

1.03

0.14

0.81*

0.09

LVPW;s

mm

1.40

0.12

1.10*

0.07

Cardiac Output

ml/min

15.2

1.0

16.3

0.8

Ejection Fraction

%

79.8

3.8

60.0*

6.2

Fractional Shortening

%

47.5

3.7

31.8*

4.1

Heart Rate

BPM

556.6

29.4

484.3

11.7

Stroke Volume

ul

27.4

2.0

33.6*

1.3

Volume;d

ul

34.6

3.8

57.0*

4.7

Volume;s

ul

7.3

2.1

23.4*

5.7

 

N = 2 m, 2f

N = 2 m, 2f

  1. LV left ventricle, AW anterior wall, ID internal diameter, PW posterior wall, d diastolic, s systolic, BPM beats per minute. *p < 0.05 paired t-test